LIU, W.,
ZHUANG, R.,
BAI, X.,
JIA, Z.,
KAPORA, E.,
TAN, W.,
FENG, S. (2020) the effect of ASB16-AS1 on CC via regulating miR-1305. Methods:
Differentially expressed lncRNAs associated
ZHAO, L.Y.,
CHEN, X.Z.,
YANG, K.,
CHEN, X.L.,
ZHANG, W.H.,
LIU, K.,
PANG, H.Y.,
GALIULLIN, D.,
WANG, H.,
SUN, L.F.,
SONG, X.H.,
ZHOU, Z.G.,
HU, J.K.,
ZHAO, Y.L.,
YU, P.W.,
WANG, J.J.,
LI, Y.,
ZHENG, J.B.,
YAO, X.Q.,
ZHAO, Q.D.,
YI, W.Q.,
YUAN, Q. (2020) differentiation, tumor size, and T and N stage. The factors, fibrinogen and T stage as well as N stage, were
KORYTINA, G.F.,
AKHMADISHINA, L.Z.,
KOCHETOVA, O.V.,
VIKTOROVA, T.V.,
AZNABAEVA, Y.G.,
ZAGIDULLIN, SH.Z. (2019) ); this association was confirmed in the subgroups
differentiated by smoking status. Markers of COPD risk were also
GAREEV, I.,
YANG, G.,
SUN, J.,
BEYLERLI, O.,
CHEN, X.,
ZHANG, D.,
ZHAO, B.,
ZHANG, R.,
SUN, Z.,
YANG, Q.,
LI, L.,
ZHAO, S.,
PAVLOV, V.,
SAFIN, S. (2020) that circulating miR-145 and miR-181b can be used to
differentiate patients with ICH from those without ICH
, Qiagen, USA), and genotyped polymorphic markers in 14
differentially expressed
chemokine genes (CCL2, CCL